Other GI monitored (diarrhoea, reflux, dyspepsia) Beyond nausea, vomiting, and constipation, the clinical trials of retatrutide also monitored a range of other gastrointestinal (GI) side effects
The FDA label for Zepbound (tirzepatide for weight management) specifically recommends monitoring heart rate at baseline and periodically during treatment, particularly in patients with cardiac disease
Understanding why this occurs and when it requires medical attention helps patients manage this common experience while continuing effective therapy
It depends, but during your first few months on tirzepatide, you might meet more frequently to keep track of how youre doing, adjust your dose if needed, and deal with any side effects that may arise
The daily recommendation for most adults is 900 mcg
The right dosage can help control blood sugar levels effectively, promote weight loss, and minimize the risk of side effects